Human targets of Pseudomonas aeruginosa pyocyanin

AUTOR(ES)

Ran, Huimin

FONTE

National Academy of Sciences

RESUMO

Pseudomonas aeruginosa produces copious amounts of the redoxactive tricyclic compound pyocyanin that kills competing microbes and mammalian cells, especially during cystic fibrosis lung infection. Cross-phylum susceptibility to pyocyanin suggests the existence of evolutionarily conserved physiological targets. We screened a Saccharomyces cerevisiae deletion library to identify presumptive pyocyanin targets with the expectation that similar targets would be conserved in humans. Fifty S. cerevisiae targets were provisionally identified, of which 60% have orthologous human counterparts. These targets encompassed major cellular pathways involved in the cell cycle, electron transport and respiration, epidermal cell growth, protein sorting, vesicle transport, and the vacuolar ATPase. Using cultured human lung epithelial cells, we showed that pyocyanin-mediated reactive oxygen intermediates inactivate human vacuolar ATPase, supporting the validity of the yeast screen. We discuss how the inactivation of VATPase may negatively impact the lung function of cystic fibrosis patients.

Documentos Relacionados

• Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro.
• Identification of Pseudomonas aeruginosa by pyocyanin production on Tech agar.
• Pyocyanin formation by some normally apyocyanogenic strains of Pseudomonas aeruginosa.
• Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.
• Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells.